Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study

DSpace Repository

Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study

Author: Schernthaner, G.; Rosas-Guzman, J.; Dotta, F.; Guerci, B.; Simo, R.; Festa, A.; Kiljanski, J.; Zhou, M.; Gallwitz, B.
Tübinger Autor(en):
Gallwitz, Baptist
Published in: Diabetes Obesity & Metabolism (2015), Bd. 17, H. 7, S. 689-698
Verlagsangabe: Wiley - Blackwell
Language: English
Full text: http://dx.doi.org/10.1111/dom.12471
ISSN: 1462-8902
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)